LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025)
LifeMD's (LFMD) quarterly Depreciation & Amortization (CF) came in at $1.8 million in Q2 2025, up 20.0% on a YoY basis from $1.5 million in Q2 2024, and up 5.88% quarter-over-quarter from $1.7 million in Q1 2025.
Powered by 
Analysis
LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025) Analysis & Trends
LifeMD (LFMD) has reported Depreciation & Amortization (CF) for 3 consecutive years, with $1.8 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Depreciation & Amortization (CF) rose 20.0% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 43.75% YoY), and the FY2024 full-year result was $6.2 million, up 44.19% from the prior year.
- Depreciation & Amortization (CF) grew to $1.8 million in Q2 2025 per LFMD's latest filing, from $1.7 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.8 million in Q2 2025 and bottomed at $1.3 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | 1.06 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | 10.70 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | 1.57 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | 1.58 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | 2.47 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | 1.58 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | - |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Sep 30, 2018 | 31,418.00 |